In iron deficiency, zinc protoporphyrin (ZPP) is produced instead of heme, and the ZPP concentration in erythrocytes is increased (normal 40 mol/mol home). We investigated the relevance of ZPP for staging iron deficiency. ZPP was determined by hematofluorometry in samples from 103 patients. Nineteen patients with iron depletion showed decreased serum ferritin (12.1 ± 4.4 pg/L) with normal ZPP and hemoglobin (Hb). Twelve patients with iron-deficient erythropoiesis had decreased ferritin (10.4 ± 2.4 pg/L), increased ZPP (72 ± 9 mol/ mol home), and normal Hb concentrations. In 72 patients with iron-deficiency anemia, ferritin was <12 g/L In mild anemia (Hb between 100 and 120 gIL, and normal erythrocyte indices), ZPP was 100 ± 16 moIImol heme. In severe anemia (Hb <100 gIL, decreased erythrocyte indices), ZPP values were significantly higher (265 ± 109 mol/mol heme). We conclude that measurements of ZPP, ferritin, and Hb can reliably be combined to classify the degree of iron deficiency.
Indexing Terms: heme/ferrftin/hemog!obin/erjthropoiesis/anemia
Iron deficiency probably represents the most common deficiency disease in humans (1)-not only in developing countries but also in the industrial countries, where the prevalence of iron deficiency in premenopausal women is estimated to be -20% (2). This widespread occurrence, the result of socioeconomic and physiological factors, is promoted by the lack of a reliable, inexpensive measure of iron deficiency and by the inability to estimate severity of iron deficiency without an extensive diagnostic workup. Iron deficiency, defined as a diminished total body iron content, has been grouped according to three stages of severity (3). A negative iron balance leads first to iron depletion, wherein total body iron is decreased but synthesis of hemoglobin is not affected. When the iron supply to the erythropoietic marrow is inadequate, the second phase of iron deficiency, iron-deficient erythropoiesis, occurs.5 When finally the iron supply is insufficient to maintain a normal hemoglobin concentration, the most severe phase of iron deficiency results, irondeficiency anemia.
Staging only by decreased sideroblast counts in bone marrow, is assumed to be present when transferrin saturation is <16% (4). Hematofluorometric determination of zinc protoporphyrin (ZPP) is used as a screening method to detect iron deficiency in blood donors (5_7) 6 The pathophysiological background of this method is the increased incorporation of zinc instead of iron into protoporphyrin IX in iron deficiency, which results in increased production of ZPP instead of heme (8) (9) (10) (11) (12) (13) (14) (15) (16) . In normal persons without iron deficiency, ZPP is 40 pmoI/mol heme (17) .
Hematofluorometric measurement of ZPP in a drop of whole blood seemed to be an ideal screening marker of iron deficiency but came into general use only for screening blood donors (5-7). Thus far, ZPP has not been used widely in clinical practice, because it often has not correlated with concentrations of ferritin, the main analyte used to assess iron metabolism.
As we showed previously, however, the nonspecificity ascribed to ZPP is chiefly caused by plasma interferences and can be avoided by a simple washing procedure
(17).
In the present study we investigated the relevance of ZPP in estimating the different stages of iron deficiency. In all, we classified 103 patients with iron deficiency according to the criteria described above.
PatIents and Methods

The study was
Results
Iron Depletion
Grade I iron deficiency was diagnosed in 19 female patients ( Blood marrow homoslderin (6 point scale, with 0 = no iron detected).
Hb,hemoglobin; SBC, sideroblast count.
female patients (Table 3) . Ferritin (9.5 ± 1.5 g/L) and transferrin saturation (10.1% ± 2.8%) were below normal. Prussian blue staining of bone marrow, performed in three patients, showed totally exhausted iron stores and decreased sideroblast counts. In all 11 cases, ZPP was moderately increased (100 ± 16 jzmol/mol heme, range 77-122).
Severe iron-deficiency anemia (hemoglobin <100 g/L, erythrocyte indices below the normal range) was diagnosed in 61 patients (9 men, 52 women; Table 3 ). In these patients ferritin concentrations (5.1 ± 3.0 ug/L) were strongly decreased, and transferrin saturation (7.5% ± 2.9%) was below normal. Prussian blue-stained bone marrow, performed in 16 patients, showed totally exhausted iron stores and decreased sideroblast counts. In all 61 cases, ZPP was strongly increased (265 ± 109 /Lmol/mol heme, range 114-661) and was significantly higher than in patients with mild iron-deficiency anemia (P <0.001). (Table 4 ). In the patient with hemochromatosis, ferritin was extremely high (2902 p.gfL) at the time of diagnosis; ZPP and hemoglobin were within the normal range (11 pmoUmol heme and 158 g/L, respectively), and transfer- 5 mo1Jmol heme, range 18-36) , whose anemia was caused by other diseases: thalassemia (n = 7), immune hemolysis (n = 5), vitamin B12 deficiency (n = 3), and folic acid deficiency (n = 1).
Continuous Iron Loss ZPP was then applied to the monitoring of iron deficiency in two patients treated by phlebotomies
DIscussion
Although Labb#{233} and Rettmer already described ZPP as a marker of iron-deficient erythropoiesis (20), ZPP has generally been used for detecting iron deficiency without consideration of the different stages of iron deficiency. However, ZPP is a reliable tool to classilS' iron deficiency. Our present data demonstrate that ZPP is not increased in the first stage, simple iron depletion, but only when erythropoiesis is affected by iron deficiency (the second stage). This explains the observation of several investigators that there is no good correlation between ferritin and ZPP (10, 11) . Iron-overloaded persons in hemochromatosis with extremely high concentrations of ferritin have normal ZPP values, as do individuals with iron depletion, whose ferritin is below normal, because the iron supply to the erythropoietic marrow is sufficient in both cases. This lack of correlation is the main reason why ZPP has not been used widely in clinical practice. High correlation between ferritin and ZPP is possible only in a group consisting mainly of healthy individuals with normal values and persons with severe iron-deficiency anemia (17) and containing no one with iron depletion and iron overload.
In healthy individuals without iron deficiency, hemoglobin and ferritin concentrations are within the normal range. ZPP in these persons (as measured in washed erythrocytes)
is 40 jmo1/mol heme (17). The earliest stage of iron deficiency, iron depletion, is defined as ferritin <35 pg/L in men and <23 agfL in women (21) . Transferrin saturation is stifi within the normal range, indicating that iron supply to the erythropoiesis is still sufficient (4). As our data show, ZPP, hemoglobin, and erythrocyte indices are still normal at this stage of iron deficiency.
The diagnosis of iron-deficient erythropoiesis requires an extensive diagnostic workup, including examination of Prussian blue-stained bone marrow smears and evaluation of the sideroblast count. Because bone marrow examination is not an option in most cases, iron-deficient erythropoiesis generally is diagnosed indirectly, by decreased transferrin saturation, considered the best marker of iron supply to the erythropoietic marrow. Values <16% are regarded as an indication of irondeficient erythropoiesis (4). As our data show, however, transferrin saturation >15% does not exclude the presence of iron-deficient erythropoiesis; e.g., patients 1 and 4 in Table 2 Table 5 ).
The predictive value of an iron-deficiency test cannot be discussed without taking into account the different stages of iron deficiency. It is important to know which stage of iron deficiency the various tests detect. Theoretically, ferritin is frequently considered to be the best marker of iron deficiency, by identifying the early stage, iron depletion. The practical significance of ferritin as a screening test for iron deficiency is, however, restricted by the high costs of the assay and the fact that ferritin is also increased in inflammatory and hepatic diseases (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Moreover, except for hemochromatosis, there is virtually no clinical relevance to knowing whether iron stores are full or only half-full. What is relevant is whether there is a sufficient iron supply to the cells, especially to the erythropoietic marrow. When the iron supply is insufficient, zinc instead of iron is incorporated into protoporphyrin IX to build ZPP; thus, as shown by our data, the beginning ZPP increase describes the moment when the intracellular iron concentration becomes insufficient and iron deficiency becomes a disease. ZPP detects the iron deficiency in a later stage than ferritin, but it always detects iron deficiency of clinical relevance. Despite detecting iron deficiency later than the storage indicator ferritin, ZPP can be the more sensitive indicator-especially in patients with inflammatory or liver diseases. In a preliminary study we have shown that ZPP is more sensitive than ferritin for the detection of iron deficiency in eiythropoietin-treated patients with endstage renal failure (19). And in the patients we had to exclude in the present study because of lack of ferritin sensitivity, we were able to diagnose and classify their iron deficiency on the basis of ZPP concentrations.
Regarding the specificity of ZPP for detecting irondeficient erythropoiesis, the only possible sources of er- In conclusion, we suggest that using ferritin, ZPP, and hemoglobin allows an easy staging of iron deficiency (Table 5) . Furthermore, ZPP can be used to screen for iron deficiency, with ZPP values 40 pmol/ mol heme excluding both iron-deficient erythropoiesis and clinically relevant iron deficiency. This study was supported by Boehringer Mannheim.
